Skip to main content
ImmuneCited

설명

In vivo angiogenesis assay results show decreased new blood vessel formation in quercetin-treated animals compared to vehicle controls in the allergic inflammation model.

Figure 5

Micrograph

Source Paper

Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.

Medicines (Basel, Switzerland) (2021)

PMID: 34065895

DOI: 10.3390/medicines8050022

Cite This Figure

![Figure 5: In vivo angiogenesis assay results show decreased new blood vessel formation in quercetin-treated animals compared to vehicle controls in the allergic inflammation model.]()

> Source: Takayuki Okumo et al. "Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.." *Medicines (Basel, Switzerland)*, 2021. PMID: [34065895](https://pubmed.ncbi.nlm.nih.gov/34065895/)
<figure>
  <img src="" alt="In vivo angiogenesis assay results show decreased new blood vessel formation in quercetin-treated animals compared to vehicle controls in the allergic inflammation model." />
  <figcaption>Figure 5. In vivo angiogenesis assay results show decreased new blood vessel formation in quercetin-treated animals compared to vehicle controls in the allergic inflammation model.<br>  Source: Takayuki Okumo et al. "Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.." <em>Medicines (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34065895/">34065895</a></figcaption>
</figure>